4.8 Article

W1335 Previous Non-Response to Infliximab Predicts Early Dose-Escalation in Adalimumab Treated Crohn's Disease Patients

Journal

GASTROENTEROLOGY
Volume 138, Issue 5, Pages S-701-S-702

Publisher

Elsevier BV
DOI: 10.1016/s0016-5085(10)63226-x

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available